Clinical assessment of 18F FTT PET versus 18F FDG PET in characterizing tumor PARP expression in ovarian cancer

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

You are going to email the following Clinical assessment of 18F FTT PET versus 18F FDG PET in characterizing tumor PARP expression in ovarian cancer

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.